{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:20:13Z","timestamp":1788643213635,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115280","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T17:32:35Z","timestamp":1690997555000},"page":"115280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Evaluation of acute toxicity and in vitro antitumor activity of a novel doxorubicin-loaded folate-coated pH-sensitive liposome"],"prefix":"10.1016","volume":"165","author":[{"given":"Juliana","family":"de Oliveira Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Salgado","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8458-0097","authenticated-orcid":false,"given":"Jana\u00edna","family":"de Alc\u00e2ntara Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geovanni Dantas","family":"Cassali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8562-8689","authenticated-orcid":false,"given":"Adriano","family":"de Paula Sabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyelle M.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica Cristina","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Lu\u00eds Branco","family":"de Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115280_bib1","first-page":"411","article-title":"Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature","volume":"6","author":"Wojtacki","year":"2000","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2023.115280_bib2","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2023.115280_bib3","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00204-016-1759-y","article-title":"Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone","volume":"90","author":"Damiani","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2023.115280_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2459\/JCM.0000000000000381","article-title":"A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology","volume":"1","author":"Spallarossa","year":"2016","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2023.115280_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.biopha.2023.115280_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.biopha.2023.115280_bib7","first-page":"1","article-title":"Use of targeted liposome-based chemotherapeutics to treat breast cancer","volume":"9","author":"Khan","year":"2015","journal-title":"Breast Cancer"},{"key":"10.1016\/j.biopha.2023.115280_bib8","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s13346-018-0551-3","article-title":"Metastatic and triple-negative breast cancer: challenges and treatment options","volume":"8","author":"Al-Mahmood","year":"2018","journal-title":"Drug. Deliv. Transl. Res."},{"key":"10.1016\/j.biopha.2023.115280_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1389450117666160208144143","article-title":"Stimuli-responsive smart liposomes in cancer targeting","volume":"19","author":"Jain","year":"2018","journal-title":"Curr. Drug. Targets"},{"key":"10.1016\/j.biopha.2023.115280_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112317","article-title":"pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment","volume":"144","author":"Nunes","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115280_bib11","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1007\/s00018-021-03850-6","article-title":"Recent advances in liposome formulations for breast cancer therapeutics","volume":"78","author":"Yang","year":"2021","journal-title":"Cell. Mol. Life. Sci."},{"key":"10.1016\/j.biopha.2023.115280_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1166\/jbn.2012.1388","article-title":"Acute toxicity study of cisplatin loaded long-circulating and pH-sensitive liposomes administered in mice","volume":"8","author":"Leite","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.biopha.2023.115280_bib13","first-page":"5259","article-title":"Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity","volume":"7","author":"Leite","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115280_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejps.2011.10.018","article-title":"Antitumoral activity and toxicity of PEG-coated and PEG-folate-coated pH-sensitive liposomes containing \u00b9\u2075\u2079Gd-DTPA-BMA in Ehrlich tumor bearing mice","volume":"45","author":"Soares","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.115280_bib15","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1166\/jbn.2013.1649","article-title":"Long-circulating, pH-sensitive liposomes versus long-circulating, non-pH-sensitive liposomes as a delivery system for tumor identification","volume":"9","author":"Barros","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.biopha.2023.115280_bib16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/MNM.0000000000000505","article-title":"Preliminary data of the antipancreatic tumor efficacy and toxicity of long-circulating and pH-sensitive liposomes containing cisplatin","volume":"37","author":"Carlesso","year":"2016","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.biopha.2023.115280_bib17","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s11307-016-0964-7","article-title":"pH-sensitive, long-circulating liposomes as an alternative tool to deliver doxorubicin into tumors: a feasibility animal study","volume":"18","author":"Silva","year":"2016","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.biopha.2023.115280_bib18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.nano.2017.03.005","article-title":"Evaluation of antitumor activity and cardiac toxicity of a bone-targeted ph-sensitive liposomal formulation in a bone metastasis tumor model in mice","volume":"13","author":"Ferreira","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2023.115280_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.taap.2018.05.037","article-title":"Toxicological study of a new doxorubicin-loaded pH-sensitive liposome: a preclinical approach","volume":"352","author":"Silva","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115280_bib20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4155\/tde.13.80","article-title":"pH-sensitive liposomes for drug delivery in cancer treatment","volume":"4","author":"Ferreira","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.biopha.2023.115280_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.09.018","article-title":"Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release","volume":"351","author":"Aghdam","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2023.115280_bib22","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0024-3205(00)00745-1","article-title":"Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice","volume":"67","author":"Oliveira","year":"2000","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115280_bib23","first-page":"8","article-title":"Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles","volume":"34","author":"Alavi","year":"2019","journal-title":"Drug. Metab. Pers. Ther."},{"key":"10.1016\/j.biopha.2023.115280_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2015.01.036","article-title":"Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel","volume":"480","author":"Chen","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115280_bib25","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1166\/jbn.2015.2132","article-title":"Folate-modified poly(malic acid) graft polymeric nanoparticles for targeted delivery of doxorubicin: synthesis, characterization and folate receptor expressed cell specificity","volume":"11","author":"Yang","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.biopha.2023.115280_bib26","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.2147\/IJN.S134284","article-title":"Folate-modified Annonaceous acetogenins nanosuspensions and their improved antitumor efficacy","volume":"12","author":"Hong","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115280_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2016.09.012","article-title":"Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo","volume":"241","author":"Alibolandi","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2023.115280_bib28","doi-asserted-by":"crossref","first-page":"10475","DOI":"10.1021\/acs.jmedchem.9b00511","article-title":"Precision cancer nanotherapy: evolving role of multifunctional nanoparticles for cancer active targeting","volume":"62","author":"Ahmad","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2023.115280_bib29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.colsurfb.2015.09.055","article-title":"Experimental design of a liposomal lipid system: a potential strategy for paclitaxel-based breast cancer treatment","volume":"163","author":"Barbosa","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2023.115280_bib30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.biopha.2017.10.135","article-title":"Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: a biodistribution study","volume":"97","author":"Monteiro","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115280_bib31","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1021\/acs.molpharmaceut.9b00329","article-title":"Paclitaxel-Loaded folate-coated ph-sensitive liposomes enhance cellular uptake and antitumor activity","volume":"16","author":"Monteiro","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2023.115280_bib32","article-title":"Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model","volume":"118","author":"Silva","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115280_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0005-2736(93)90105-9","article-title":"Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases","volume":"1151","author":"Haran","year":"1993","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.biopha.2023.115280_bib34","first-page":"243","article-title":"5\u03b1-Tocopherol succinate improves encapsulation and anticancer activity of doxorubicin loaded in solid lipid nanoparticles","volume":"164","author":"Oliveira","year":"2016","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.biopha.2023.115280_bib35","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2023.115280_bib36","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.biopha.2018.04.139","article-title":"7\u03b1- Tocopherol succinate loaded nano-structed lipid carriers improves antitumor activity of doxorubicin in breast cancer models in vivo","volume":"103","author":"Fernandes","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115280_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jsb.2017.12.007","article-title":"Translocation of Epidermal Growth Factor (EGF) to the nucleus has distinct kinetics between adipose tissue-derived mesenchymal stem cells and a mesenchymal cancer cell lineage","volume":"202","author":"Faraco","year":"2018","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.biopha.2023.115280_bib38","unstructured":"Organization For Economic Co-Operation And Development (OECD). Guideline for Testing of Chemicals 423: Acute Oral Toxicity \u2013 Acute Toxic Class Method, 2001."},{"key":"10.1016\/j.biopha.2023.115280_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biomaterials.2015.03.021","article-title":"Versatile preparation of intracellular-acidity-sensitive oxime-linked polysaccharide-doxorubicin conjugate for malignancy therapeutic","volume":"54","author":"Xu","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2023.115280_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mrrev.2012.08.001","article-title":"In vitro cell migration and invasion assays","volume":"753","author":"Kramer","year":"2013","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"10.1016\/j.biopha.2023.115280_bib41","doi-asserted-by":"crossref","first-page":"10175","DOI":"10.1021\/nn404407g","article-title":"Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release","volume":"7","author":"Basuki","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2023.115280_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/med.2610130404","article-title":"Stability of liposomal doxorubicin formulations: problems and prospects","volume":"13","author":"Barenholz","year":"1993","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2023.115280_bib43","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.2147\/IJN.S109966","article-title":"Development of a bone-targeted pH-sensitive liposomal formulation containing doxorubicin: physicochemical characterization, cytotoxicity, and biodistribution evaluation in a mouse model of bone metastasis","volume":"11","author":"Ferreira","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115280_bib44","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0006-3495(92)81897-0","article-title":"Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential","volume":"61","author":"Woodle","year":"1992","journal-title":"Biophys. J."},{"key":"10.1016\/j.biopha.2023.115280_bib45","article-title":"Preparation, physicochemical characterization, and cell viability evaluation of long-circulating and pH-sensitive liposomes containing ursolic acid","volume":"2013","author":"Lopes","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2023.115280_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0076-6879(05)91004-5","article-title":"The liposomal formulation of doxorubicin","volume":"391","author":"Abraham","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.biopha.2023.115280_bib47","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.2147\/IJN.S165210","article-title":"Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional\/herbal medicines in cancer therapy: a systematic review","volume":"13","author":"Muhamad","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115280_bib48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fonc.2013.00249","article-title":"Prospects in folate receptor-targeted radionuclide therapy","volume":"3","author":"M\u00fcller","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2023.115280_bib49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41571-020-0339-5","article-title":"Exploiting the folate receptor \u03b1 in oncology","volume":"17","author":"Scaranti","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115280_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2014.03.033","article-title":"Targeted poly (L-\u03b3-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells","volume":"467","author":"Tavassolian","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115280_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijbiomac.2020.02.106","article-title":"Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles","volume":"152","author":"Akbarian","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2023.115280_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119449","article-title":"Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft","volume":"585","author":"Kazi","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115280_bib53","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/1535-7163.1505.3.12","article-title":"Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment","volume":"3","author":"Jhaveri","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2023.115280_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jconrel.2016.09.010","article-title":"Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro","volume":"243","author":"Marshalek","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2023.115280_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jphotobiol.2015.05.008","article-title":"Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell lines","volume":"149","author":"Banu","year":"2015","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.biopha.2023.115280_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.111918","article-title":"Evaluating internalization and recycling of folate receptors in breast cancer cells using quantum dots","volume":"209","author":"Monteiro","year":"2020","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.biopha.2023.115280_bib57","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/pharmaceutics11080381","article-title":"Formulation strategies for folate-targeted liposomes and their biomedical applications","volume":"11","author":"Kumar","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115280_bib58","doi-asserted-by":"crossref","first-page":"511","DOI":"10.5507\/bp.2014.004","article-title":"Biomarkers for the early detection of anthracycline-induced cardiotoxicity: current status","volume":"158","author":"Horacek","year":"2014","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Republic"},{"key":"10.1016\/j.biopha.2023.115280_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yrtph.2016.08.002","article-title":"Slow infusion rate of doxorubicin induces higher pro-inflammatory cytokine production","volume":"81","author":"Tien","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115280_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115280_bib61","first-page":"96","article-title":"Practical murine hematopathology: a comparative review and implications for research","volume":"65","author":"O'Connell","year":"2015","journal-title":"Comp. Med."},{"key":"10.1016\/j.biopha.2023.115280_bib62","first-page":"1","article-title":"Protective effects of madecassoside against Doxorubicin induced nephrotoxicity in vivo and in vitro","volume":"14","author":"Su","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115280_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2329-6771.1000193","article-title":"Reduction of hepatotoxicity induced by doxorubicin","volume":"6","author":"Bengaied","year":"2017","journal-title":"J. Integr. Oncol."},{"key":"10.1016\/j.biopha.2023.115280_bib64","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-0035-1569447","article-title":"The comparison of biodistribution, efficacy and toxicity of two PEGylated liposomal doxorubicin formulations in mice bearing C-26 colon carcinoma: a preclinical study","volume":"66","author":"Razavi-Azarkhiavi","year":"2016","journal-title":"Drug. Res."},{"key":"10.1016\/j.biopha.2023.115280_bib65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","article-title":"Adriamycin nephropathy: a model of focal segmental glomerulosclerosis","volume":"16","author":"Lee","year":"2011","journal-title":"Nephrology"},{"key":"10.1016\/j.biopha.2023.115280_bib66","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9507563","article-title":"Possible protective effect of diacerein on doxorubicin-induced nephrotoxicity in rats","volume":"2016","author":"Refaie","year":"2016","journal-title":"J. Toxicol."},{"key":"10.1016\/j.biopha.2023.115280_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.01.002","article-title":"Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations","volume":"519","author":"Luo","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115280_bib68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/MNM.0000000000000443","article-title":"Technetium-99m-labeled doxorubicin as an imaging probe for murine breast tumor (4T1 cell line) identification","volume":"37","author":"Fernandes","year":"2016","journal-title":"Nucl. Med. Commun."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223010715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223010715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:36:59Z","timestamp":1777880219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223010715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":68,"alternative-id":["S0753332223010715"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115280","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of acute toxicity and in vitro antitumor activity of a novel doxorubicin-loaded folate-coated pH-sensitive liposome","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115280"}}